503A pharmacies Still legally permitted to compound semaglutide for individual patients with documented clinical need (e.g., allergy to an inactive ingredient in the brand-name product, specific dose requirements not available in FDA-approved formulations)
This test maps 14 pathways, 49 peptides, and 150+ genetic insights unique to your biology
Campbell JE, Mller TD, Finan B, DiMarchi RD, Tschp MH, DAlessio DA
Expenses incurred for physician-supervised programs, diagnostic services, or prescription weight loss medication can qualify if they serve a medical purpose
Expiration dates set by licensed 503A compounding pharmacies represent the absolute final date when full potency is guaranteed, regardless of storage conditions